These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9221752)

  • 1. Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy.
    Wick M; Dubey P; Koeppen H; Siegel CT; Fields PE; Chen L; Bluestone JA; Schreiber H
    J Exp Med; 1997 Jul; 186(2):229-38. PubMed ID: 9221752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animals bearing malignant grafts reject normal grafts that express through gene transfer the same antigen.
    Perdrizet GA; Ross SR; Stauss HJ; Singh S; Koeppen H; Schreiber H
    J Exp Med; 1990 Apr; 171(4):1205-20. PubMed ID: 2324687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
    Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
    Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cells recognize common antigenic motifs shared by H-2Dd, H-2Ld and possibly H-2Dr molecules expressed on bone marrow cells.
    Yu YY; Forman J; Aldrich C; Blazar B; Flaherty L; Kumar V; Bennett M
    Int Immunol; 1994 Sep; 6(9):1297-306. PubMed ID: 7529556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and manipulation of T cell immunity to skin grafts expressing a transgenic minor antigen.
    Valujskikh A; Matesic D; Heeger PS
    Transplantation; 1999 Oct; 68(7):1029-36. PubMed ID: 10532546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage MHC and T-cell receptors essential for rejection of allografted skin and lymphoma.
    Tashiro-Yamaji J; Maeda S; Ikawa M; Okabe M; Kubota T; Yoshida R
    Transplantation; 2013 Aug; 96(3):251-7. PubMed ID: 23836286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for clonal deletion and clonal anergy after intrathymic antigen injection in a transplantation model.
    Gillanders WE; Arima T; Tu F; Hansen TH; Flye MW
    Transplantation; 1997 Oct; 64(8):1159-66. PubMed ID: 9355834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ effector cells responding to residual class I antigens, with help from CD4+ cells stimulated indirectly, cause rejection of "major histocompatibility complex-deficient" skin grafts.
    Lee RS; Grusby MJ; Laufer TM; Colvin R; Glimcher LH; Auchincloss H
    Transplantation; 1997 Apr; 63(8):1123-33. PubMed ID: 9133474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of the mutated H-2Kbm1 antigen(s). Test of thyroid graft rejection between B6.C-H-2bm1 and C57BL/6 mice following reciprocal immunization with normal versus malignant cells.
    Isakov N; Segal S
    Immunobiology; 1983 Dec; 165(5):485-99. PubMed ID: 6363278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo induction of antigen-specific transplantation tolerance to Qa1a by exposure to alloantigen in the absence of T-cell help.
    Rees MA; Rosenberg AS; Munitz TI; Singer A
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2765-9. PubMed ID: 2138785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rejection of grafts with no H-2 disparity in TAP1 mutant mice: CD4 T cells are important effector cells and self H-2b class I molecules are target.
    Suárez IM; Benvenutti LA; Noronh I; Van Kaer L; Kalil J; Coelho V
    Transpl Immunol; 2002 May; 9(2-4):101-10. PubMed ID: 12180815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of high-avidity T cells by thymic epithelium.
    Hoffmann MW; Heath WR; Ruschmeyer D; Miller JF
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9851-5. PubMed ID: 7568231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ T cells are necessary for recognition of allelic, but not locus-mismatched or xeno-, HLA class I transplantation antigens.
    Borenstein SH; Graham J; Zhang XL; Chamberlain JW
    J Immunol; 2000 Sep; 165(5):2341-53. PubMed ID: 10946256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell receptor expression in C57BL/6 mice that reject or are rendered tolerant to bm1 cardiac grafts.
    Mohiuddin M; Ruggiero V; Shen Z; DiSesa VJ
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):310-3. PubMed ID: 8751496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral tolerance in transgenic mice expressing class I MHC L(d) only on cardiac cells.
    Margenthaler JA; Kataoka M; Flye MW
    Transpl Immunol; 2004 Jan; 12(2):133-41. PubMed ID: 14967311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A direct comparison of rejection by CD8 and CD4 T cells in a transgenic model of allotransplantation.
    Porrett PM; Lee MK; Lian MM; Wang J; Caton AJ; Deng S; Markmann JF; Moore DJ
    Arch Immunol Ther Exp (Warsz); 2008; 56(3):193-200. PubMed ID: 18512028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of antigenic variants from a nonantigenic murine tumor cell line by transfection with a gene encoding a novel tumor-specific transplantation antigen.
    Kaba DS; McIntyre BW; Kripke ML; Goodenow RS; Schreiber H; Ananthaswamy HN
    Cancer Res; 1989 Jan; 49(1):38-43. PubMed ID: 2783244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated graft rejection observed in two lines of human histocompatibility leukocyte antigen class I transgenic mice.
    Ando Y; Beck Y; Tomikawa S; Eriguchi M; Muto T; Takiguchi M
    Transplantation; 1999 Sep; 68(6):904-8. PubMed ID: 10515394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell activation and thymic tolerance induction require different adhesion intensities of the CD8 co-receptor.
    Knobloch M; Schönrich G; Schenkel J; Malissen M; Malissen B; Schmitt-Verhulst AM; Hämmerling GJ; Arnold B
    Int Immunol; 1992 Oct; 4(10):1169-74. PubMed ID: 1489732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.